NVE Corporation is a high-quality, high-margin niche semiconductor business, but the stock's rich valuation, elevated leverage, and dividend safety warning temper the otherwise strong fundamental profile.
Thesis pillars
- Expensive Valuation→Stable
- High Quality High Roe Business→Stable
- Leverage Penalty Flagged→Stable
- +2 more pillars — see the Why tab for full reasoning
NVE Corporation (NVEC) Stock Analysis
Temporary headwind edge
Technology · Semiconductors
Wait — supporting gate not met yet. Price is at or below entry $100.60 but weak momentum; insider activity concern; recent C-suite change still blocks BUY_NOW. Key risks: Sector modifier (Technology): -0.8; Expensive valuation.
NVE Corporation develops and manufactures spintronic sensors, couplers and MRAM memory products for industrial, medical and factory-automation applications, operating its own U.S. wafer fabrication and test facility in Minnesota. The company relies on several large customers,... Read more
Wait — supporting gate not met yet. Price is at or below entry $100.60 but weak momentum; insider activity concern; recent C-suite change still blocks BUY_NOW. Key risks: Sector modifier (Technology): -0.8; Expensive valuation. Chart setup: No clear chart pattern; technical signals are mixed. Wide-moat business. Accumulate on weakness. Score 6.2/10, moderate confidence.
Passes 4/8 gates (news events none recent, earnings proximity 48d clear, semi cycle peak clear, materials cycle peak clear). Fails on weak momentum and clean insider activity. Suitability: aggressive.
About NVE Corporation
About NVE Corporation
NVE Corporation manufactures spintronic sensors, couplers and MRAM memory devices, relying on several large customers, including Abbott Laboratories, distributors and private-brand partners, for a significant percentage of revenue as of its March 31, 2026 fiscal year end. The Minnesota-based company, founded in 1989, has been awarded more than $50 million in government research contracts since inception and employed 42 people, 40 of them full-time, as of fiscal year end.
NVE earns revenue from three product lines: magnetic sensors used in factory automation, robotics and implantable medical devices; couplers that electrically isolate and transmit data between electronic subsystems in power conversion and industrial networking applications; and low-bit-density MRAM aimed at military, industrial and antitamper markets. The company operates its own front-end wafer fabrication and back-end testing facility, which it considers an advantage over competitors that outsource manufacturing, though most of its device packaging services take place in Asia. NVE sells through distributors including America II Electronics, Angst+Pfister Sensors and Power, and Digi-Key, supplemented by private-brand partnerships with large integrated device manufacturers.
Show full overview
NVE announced on June 22, 2026 that President and CEO Daniel A. Baker will retire effective at the August 6, 2026 annual meeting, to be succeeded by Peter Eames, the company's Vice President of Advanced Technology since 2016, with Baker remaining as Board chairman pending shareholder approval. The leadership change comes as the company continues to disclose reliance on several large customers, including Abbott Laboratories, for a significant percentage of revenue, a concentration the 10-K says could materially harm results if one or more of these customers were lost.
See also: Technology · Semiconductors
From NVE Corporation's most recent 10-K filing, extracted July 6, 2026.
Recent developments
updated 2026-09-03Recent Developments — NVE Corporation
Latest news
- NEWS NVE Corp (NVEC) CEO sells 20,000 shares after exercising options - Stock Titan — Stock Titan negative
- NEWS NVE Corp (NVEC) CEO sells 20,000 shares after exercising options - stocktitan.net — stocktitan.net negative
- NEWS NVE (NVEC) Q1 2027 earnings summary - Quartr — Quartr neutral
- NEWS NVE (NVEC) Earnings Update: The Company Lists Its Latest Available Figures for the Current Session; Market Reaction: The — vinanet.vn neutral
- NEWS NVE (NVEC) Short Interest & Short Float | Updated Aug 2026 - MarketBeat — MarketBeat negative
Generated 2026-09-03T14:22:18Z.
Upcoming dated catalysts
Thesis
Key Metrics
Quality Signals
Concentration Risks(10-K Item 1A)
- MEDIUMCustomerAbbott Laboratories and other large customers10-K Item 1: 'We rely on several large customers for a significant percentage of our revenue, including Abbott Laboratories, certain distributors, and certain other customers.'
- MEDIUMSupplierpackaging services in Asia10-K Item 1: 'We have worldwide wafer sources; most of our packaging services take place in Asia.'
Material Events(8-K, last 90d)
- 2026-06-22Item 5.02MEDIUMNVE Corporation announced CEO Daniel A. Baker will retire effective at the August 6, 2026 annual meeting, succeeded by Peter Eames, currently VP of Advanced Technology; Baker will remain Board chairman, a clean planned handoff.SEC filing →
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
2 floor-breakers·2 ceiling hits
Momentum below the gate floor. Component breakdown shows what dragged the score down.static
Priced at a premium — multiples above sector norms. Needs delivery on growth + margins to justify.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Wait — supporting gate not met yet. Price is at or below entry $100.60 but weak momentum; insider activity concern; recent C-suite change still blocks BUY_NOW. Key risks: Sector modifier (Technology): -0.8; Expensive valuation. Chart setup: No clear chart pattern; technical signals are mixed. Wide-moat business. Accumulate on weakness. Target $129.77 (+33.2%), stop $90.51 (−7.6%), A.R:R 0.0:1. Score 6.2/10, moderate confidence.
Take-profit target: $129.77 (+40.6% upside). Target $129.77 (+33.2%), stop $90.51 (−7.6%), A.R:R 0.0:1. Stop-loss: $90.51.
Sector modifier (Technology): -0.8; Expensive valuation; Negative momentum.
NVE Corporation trades at a P/E of 26.4 (forward 34.8). TrendMatrix value score: 3.0/10. Verdict: Buy (Wait for Entry).
6 analysts cover NVEC with a consensus score of 2.2/5.
What does NVE Corporation do?NVE Corporation develops and manufactures spintronic sensors, couplers and MRAM memory products for industrial, medical...
NVE Corporation develops and manufactures spintronic sensors, couplers and MRAM memory products for industrial, medical and factory-automation applications, operating its own U.S. wafer fabrication and test facility in Minnesota. The company relies on several large customers, including Abbott Laboratories, distributors and private-brand partners, for a significant percentage of its revenue, and had 42 employees as of March 31, 2026, its fiscal year end.